{"id":"W1995811281","doi":"10.1007/s00280-006-0362-y","title":"Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors","year":2006,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Pharmacokinetics; Tolerability; Neutropenia; Taxane; Internal medicine; Refractory (planetary science); Paclitaxel; Adverse effect; Toxicity; Pharmacology; Oncology; Chemotherapy; Gastroenterology; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008293904,0.00180789,0.002434768,0.0004172068,0.0005807755,0.0007171736,0.0007563283,0.001134039,0.005325262],"category_scores_gemma":[0.0007504913,0.0005375384,0.001047957,0.0003205521,0.00117105,0.0007210249,0.0003937412,0.002897096,0.00132967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006900408,"about_ca_system_score_gemma":0.001564491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0011632,"about_ca_topic_score_gemma":0.001863781,"domain_scores_codex":[0.9997336,0.0001275164,0.00001006418,0.00004529625,0.000016666,0.00006687843],"domain_scores_gemma":[0.9995,0.00008654224,0.00006528291,0.00005080414,0.00002957414,0.0002677825],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8724461,0.0446729,0.003123045,0.0004611527,0.0006652767,0.0001370682,0.0002047595,0.001799779,0.02330346,0.0004802195,0.004098106,0.04860823],"study_design_scores_gemma":[0.6427007,0.3452679,0.006006973,0.00002294147,0.0003208723,0.0001296415,0.00005806205,0.0008999704,0.002450802,0.0003300821,0.001792049,0.00001996506],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934168,0.0009957353,0.0004421824,0.0006374677,0.0001456163,0.001345627,0.0008031805,0.0001219236,0.002091528],"genre_scores_gemma":[0.9867247,0.001798507,0.001176953,0.000698019,0.0002784686,0.002571585,0.001758497,0.00004561408,0.004947643],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005325262,"threshold_uncertainty_score":0.01781476,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01851690814974668,"score_gpt":0.3711569498190604,"score_spread":0.3526400416693138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}